The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by rising vaccine uptake, impr ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

The artificial intelligence tool is the first to use large language modeling to predict infectious disease risk ...

In this episode, Alexandra Hogue, Director of Operations at Orbis Surgery Center in Houston, shares insights on ASC growth, navigating reimbursement changes, and how AI and automation are shaping ...